It is pretty easy to see with her many other public staements over the years that she is "PRO" Teva.......repeatedly.
Doesn't mean that what she says about delay may not be correct......just that she is clearly biased.
There does appear to be circumstantial evidence that the FDA capoxone decision will be delayed based on the peptimmune statement and Wheeler's comment about how the capoxone process is seemingly a bit more laborious than for lovenox. But all we have is pure speculation.
IMO, it would be nice to hear of MNTA's other shots on goal......they are clearly competent with proof of concept......but our singular focus on lovenox and capaxone does little justice to its potential. Longing for the day when we are focused on 5 or 6 opportunities ;)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.